Ceftriaxone

• ANTIBIOBONTA - Assessment of the interest of a peri-operative antibiotic strategy applied to patients with asymptomatic bacteriuria undergoi… Pending
  2024-515107-19-00 Phase III 1 country Centre Hospitalier Universitaire De Lille
• Comparing the efficacy and safety of extended (3 h) and intermittent infusion (0.5 h) of beta-lactams (cefepime, ceftriaxone, meropenem, pip… Pending
  2024-518115-19-02 Phase IV 1 country Semmelweis University
• Comparison of two prophylactic antibiotic regimens in case of preterm prelabor rupture of membranes before 34 weeks of gestation: a randomiz… Pending
  2025-520842-31-00 Phase III 1 country Assistance Publique Hopitaux De Paris
• Pilot randomized controlled trial of the prevention of early respiratory tract infections in intubated patients. Comparison of the safety an… Pending
  2025-521454-42-00 Phase IV 1 country Hospital Clinico San Carlos
• Antibiotic Treatment Trial in Acute Coronary Syndrome Pending
  2025-522136-14-00 Phase III/IV 1 country TAYS Sydaenkeskus Oy
• Efficacy and safety of Dalbavancin in the treatment of infective Endocarditis caused by gram-positive cocci Pending
  2026-526149-91-00 Phase III 1 country Friedrich-Schiller-Universitaet Jena
• STUDY TO FIND OUT WHETHER A SHORTER ANTIBIOTIC TREATMENT (7 DAYS) IS AS EFFECTIVE AND SAFE AS THE USUAL ONE (14 DAYS) IN PATIENTS WITH AN IN… Recruiting
  2025-523120-53-00 Phase III/IV 1 country Bellvitge University Hospital; Fundacio Institut D'Investigacio Biomedica De Bel…
• Benefits of early discontinuation of antibiotic therapy versus standard management in elderly patients hospitalized for viral infection: a m… Recruiting
  2024-515695-13-00 Phase III/IV 1 country Centre Hospitalier Universitaire Amiens Picardie
• Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia: A randomized, non-blinded, no… Recruiting
  2024-519186-21-01 Phase IV 1 country Hvidovre Hospital
• Efficacy and safety of different antimicrobial DURATions for the treatment of Infections associated with Osteosynthesis Material implanted a… Recruiting
  2023-508442-18-00 Phase III 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
• STRAtified Dosing based on Augmented renal clearance for CEFtriaxone in patients with severe community-acquired pneumonia: the STRADA-CEF tr… Recruiting
  2022-502013-28-00 Phase IV 1 country UZ Leuven
• SAVE- oral antibiotics for treatment of vertebral osteomyelitis Recruiting
  2023-507617-96-01 Phase IV 1 country Rigshospitalet
• CUSTOMIZED ANTIBIOTIC TREATMENT DURATION AMONG HOSPITALIZED PATIENTS WITH MODERATELY SEVERE COMMUNITY-ACQUIRED PNEUMONIA [CAT-CAP] Recruiting
  2023-504208-27-00 Phase III 1 country Assistance Publique Hopitaux De Paris
• A RANDOMIZED PROSPECTIVE CLINICAL TRIAL TO ASSESS PROCALCITONIN-GUIDANCE AND MOLECULAR-GUIDED DIAGNOSIS AS MAINSTAY FOR THERAPY OF SEVERE IN… Ended
  2022-502962-26-00 Phase III 1 country Hellenic Institute For The Study Of Sepsis
• Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP) Ended
  2023-507889-89-00 Phase III 13 countries Universitair Medisch Centrum Utrecht
• COTRIVAP - Efficacy of cotrimoxazole as a de-escalation treatment of Ventilator-Associated Pneumonia in intensive care unit Ended
  2023-505108-52-00 Phase III 1 country Assistance Publique Hopitaux De Paris

Showing 1–16 of 16 trials